Successfully tested 10 new compounds against cancer

On June 14, 2007, Taiwan experts said the new 10 fat-sugar compounds tests have yielded such encouraging results.

These new compounds were created by a research team led by Dr. Wong Chi-huey, President of Academia Sinica - Taiwan's highest academic research institute. He is also a veteran expert in the structure and function of the road.

The creation of these 10 new substances is the result of efforts to improve compound A-Galcer, discovered in Japan in 1995. The names of these 10 compounds have not been published yet.

X-ray images of breast tumors to detect breast cancer.(Photo: AFP)

According to Academia Sinica, test results on mice have demonstrated the anticancer effect of these compounds. Accordingly, mice with lung cancer treated with these new drugs had a much longer life expectancy than mice treated with A-Galcer. Test results show that A-Galcer works to improve immunity by supporting some proteins, but at the same time it also causes damage to some other proteins, thereby inhibiting immune function. In general, the anti-cancer effect of A-Galcer is weak.

Meanwhile, when treated with new substances for 6 weeks, mice with lung cancer had better health.

For mice with breast cancer, the ability to inhibit cancer cell growth was recorded in 75% of all mice treated with new substances, while in mice treated with A-Galcer, this rate is only 50%.

"This is an innovative strategy for the treatment of cancer ," said Alice Yu, an expert in the evaluation of these new compounds . To date, most anticancer drugs cause many side effects, such as hair loss and nausea. Meanwhile, these new substances have very few side effects, as they are designed to enhance the immune system's ability to directly attack cancer cells'.

Excited by the results of the experiment, Dr. Chang Ya-jen, a member of the research team, said the new substances could be used to produce a drug that acts as an 'alternative therapy'. to fight cancer in the future.

Ms. Ya-jen said: 'This research opens new hope for cancer patients, because such drugs not only have the ability to prolong life, but also improve the quality of life of patients in time to fight against disease '.

However, experts say it may take up to 10 more years to complete clinical trials before a new anti-cancer drug can be produced.

Research by Dr. Wong Chi-huey and colleagues has just been published in the electronic edition of Proceedings of the National Academy of Sciences (USA).

Quang Thinh